TGFB1 anticorps (AA 22-50)
Aperçu rapide pour TGFB1 anticorps (AA 22-50) (ABIN1809827)
Antigène
Voir toutes TGFB1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 22-50
-
Specificité
- This TGFB1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 22-50 amino acids from the N-terminal region of human TGFB1.
-
Purification
- Protein A purified
-
-
-
-
Indications d'application
- Approved: IF (1:10 - 1:50), IHC, IHC-P (1:10 - 1:50), WB (1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Date de péremption
- 6 months
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Autre désignation
- TGFB1 / TGF Beta 1
-
Sujet
-
Name/Gene ID: TGFB1
Family: TGF beta
Synonyms: TGFB1, CED, DPD1, Diaphyseal dysplasia 1, LAP, Latency-associated peptide, TGF Beta, TGFbeta, TGF-beta 1 protein, TGF-beta-1, TGFB -
ID gène
- 7040
-
UniProt
- P01137
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints
Antigène
-